chr16-1839264-CAA-C
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_001163560.3(MEIOB):βc.1207_1208delβ(p.Leu403GlyfsTer6) variant causes a frameshift change. The variant allele was found at a frequency of 0.000212 in 1,605,570 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (β ). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: π 0.00011 ( 0 hom., cov: 32)
Exomes π: 0.00022 ( 0 hom. )
Consequence
MEIOB
NM_001163560.3 frameshift
NM_001163560.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.42
Genes affected
MEIOB (HGNC:28569): (meiosis specific with OB-fold) Predicted to enable chromatin binding activity; single-stranded DNA 3'-5' exodeoxyribonuclease activity; and single-stranded DNA binding activity. Predicted to be involved in double-strand break repair via homologous recombination; fertilization; and meiotic nuclear division. Predicted to be located in cytoplasm. Implicated in spermatogenic failure 22. [provided by Alliance of Genome Resources, Apr 2022]
FAHD1 (HGNC:14169): (fumarylacetoacetate hydrolase domain containing 1) Enables acetylpyruvate hydrolase activity; fumarylpyruvate hydrolase activity; and oxaloacetate decarboxylase activity. Located in cytosol; mitochondrion; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 16-1839264-CAA-C is Pathogenic according to our data. Variant chr16-1839264-CAA-C is described in ClinVar as [Pathogenic]. Clinvar id is 2078114.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MEIOB | NM_001163560.3 | c.1207_1208del | p.Leu403GlyfsTer6 | frameshift_variant | 12/14 | ENST00000325962.9 | NP_001157032.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MEIOB | ENST00000325962.9 | c.1207_1208del | p.Leu403GlyfsTer6 | frameshift_variant | 12/14 | 5 | NM_001163560.3 | ENSP00000314484 | P1 | |
ENST00000470044.5 | c.586_587del | p.Leu196GlyfsTer6 | frameshift_variant | 11/13 | 2 | ENSP00000457416 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152156Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
17
AN:
152156
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000696 AC: 17AN: 244296Hom.: 0 AF XY: 0.0000758 AC XY: 10AN XY: 131970
GnomAD3 exomes
AF:
AC:
17
AN:
244296
Hom.:
AF XY:
AC XY:
10
AN XY:
131970
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000222 AC: 323AN: 1453414Hom.: 0 AF XY: 0.000231 AC XY: 167AN XY: 722438
GnomAD4 exome
AF:
AC:
323
AN:
1453414
Hom.:
AF XY:
AC XY:
167
AN XY:
722438
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000112 AC: 17AN: 152156Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74334
GnomAD4 genome
AF:
AC:
17
AN:
152156
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
74334
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 27, 2022 | This sequence change creates a premature translational stop signal (p.Leu403Glyfs*6) in the MEIOB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MEIOB are known to be pathogenic (PMID: 30838384). This variant is present in population databases (rs745502213, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with MEIOB-related conditions. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at